Skip to main content

19 March 2024 Corina Härning, Stabsstelle Kommunikation und Marketing, University of Augsburg

Researchers at Augsburg University Medicine have discovered a possible early detection method of the rare Borna virus. Their results have been published in the highly renowned medical journal “The Lancet.” In humans the virus triggers inflammation in the brain which is almost always deadly and is transmitted to humans by shrews.

Borna disease virus 1 (BoDV-1) has long been recognised as a pathogen that causes Borna’s disease in horses, sheep, and other mammals in Central Europe. In 2018, the virus was first identified as the cause of severe brain inflammation in humans. Two to six people are affected by the disease each year in Germany. The virus is endemic to Bavaria, meaning it permanently exists there.

"Only recently, we were able to make the difficult diagnosis of Borna encephalitis in a 71-year-old female patient. She had continuously deteriorated neurologically over several weeks from full health and ultimately died as a result of the severe brain inflammation," explains Prof. Dr. Markus Naumann, Director of the Clinic of Neurology at Augsburg University Hospital. At fist all examinations such as MRI scans of the brain and extensive laboratory and cerebrospinal fluid tests were completely normal.

Early detection of encephalitis successful

The doctors then used a nuclear medical procedure that is normally used to diagnose tumour diseases and inflammation: 18Fluorodeoxyglucose positron emission tomography/computer tomography (18F-FDG PET/CT). Via this procedure, they were able to determine a pathologically altered glucose metabolism in the patient’s brain. “This is remarkable because it was conspicuously visible long before we could detect the Borna virus with repeated MRI scans and antibody tests," explains Prof. Dr Antonios Bayas. He is Head of the Clinical Neuroimmunology Section at the Clinic of Neurology.

With a detailed description of the case in the journal “The Lancet,” Naumann, Bayas, and other participating researchers want to inform other doctors worldwide that with severe cases of brain inflammation with an unclear cause an infection caused by Borna virus should be tested for. “This applies above all else if the patient is in a risk area. The 18F-FDG PET/CT can provide a very early diagnostic lead here,” says Bayas.

What is the Borna virus?

According to information from the Robert Koch Institute, infected patients initially present with headaches, fever, and a general feeling of being ill. All known cases of the disease to date have been followed by neurological symptoms, e.g., behavioural abnormalities and speech and gait disorders. As the disease progresses, people fall into a coma within a few days or weeks. The infection is almost always deadly. There is currently no specific therapy for treating Borna virus infections.

The disease is contracted through shrews, either by direct contact with an animal or their droppings. The shrews live on fallow land, e.g., road embankments, stone walls, or under hedges, and are very shy and nocturnal so that humans only rarely encounter them. Other animals, e.g., infected horses, sheep, and other mammals, are currently considered non-infectious for humans.

Contact for scientific information:

Prof. Dr. med. Markus Naumann
Lehrstuhlinhaber Neurologie
Direktor Klinik der Neurologie und klinische Neurophysiologie

Telefon: +49 (0) 821 400-2991
E-Mail: markus.naumann@med.uni-augsburg.de

Prof. Dr. med. Antonios Bayas
Leitender Oberarzt und stellvertretender Direktor
Klinik der Neurologie und klinische Neurophysiologie

Telefon: 0821 400-2861
E-Mail: antonios.bayas@uk-augsburg.de

Original publication:

Antonios Bayas*, Martina Menacher*, Constantin Lapa, Dennis Tappe, Christoph Maurer, Friederike Liesche-Starnecker, Hauke Schneider, Markus Naumann (*Erstautor:in): 18Fluorodeoxyglucose PET/CT as possible early diagnostic tool preceding MRI changes in Borna disease virus 1 encephalitis. The Lancet. Volume 403, Issue 10427.

Back to top Icon

This website uses cookies and the Matomo web analysis tool. By continuing to browse you agree to our use of cookies. Change your settings here. More information.